← Insider buys
MNKD

MannKind Corporation · Healthcare

CEO Michael Castagna sold $395K of MannKind Corporation

Sold$395,482
$6.01Price
65,804Shares
−3%Stake

What MNKD did after the filing

Filed Dec 19Copier in Dec 22
The stock from Mon, Dec 22 open, $5.86
−6.0%
S&P 500, same days
−0.9%

Measured over 30 trading days, to the Feb 5 close.

Traded Wed, Dec 17. Filed Fri, Dec 19, 8:00 PM ET, after the close. Returns use the Dec 22 open and the Feb 5 close. Not investment advice.